Northland Capital Markets Initiates Coverage On Cardlytics With Outperform Rating, Announces Price Target of $14
Northland Capital Markets Initiates Coverage On Cardlytics With Outperform Rating, Announces Price Target of $14
Northland資本市場啓動對cardlytics的研究覆蓋，給予跑贏大盤評級，並公佈14美元的目標價。
Northland Capital Markets analyst Luke Horton initiates coverage on Cardlytics (NASDAQ:CDLX) with a Outperform rating and announces Price Target of $14.
Northland Capital Market分析師Luke Horton以超常表現的評級啓動了Cardlytics（納斯達克：CDLX）的覆蓋並宣佈了14美元的目標價格。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。